Multidisciplinary approach to childhood epilepsy: Exploring the scientific rationale and practical aspects of implementation

Journal of Child Neurology

Volumn 19, Issue 5, 2004, Pages 362-378

  Goldstein, Joshua ^a   Plioplys, Sigita ^a   Zelko, Frank ^a   Mass, Sarah ^a   Corns, Christine ^a   Blaufuss, Robert ^a   Nordli, Douglas ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; POTASSIUM; POTASSIUM CHANNEL; PRIMIDONE; SODIUM; SODIUM CHANNEL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

AGGRESSION; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE CONTROL; DISEASE PREDISPOSITION; DRUG MECHANISM; FAMILY; GENE MUTATION; GENETIC TRAIT; HUMAN; HYPERACTIVITY; IRRITABILITY; LEARNING DISORDER; MENTAL DISEASE; MOOD; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; NONHUMAN; NURSE; PATIENT CARE; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SIDE EFFECT; SOCIAL EVOLUTION; SOCIAL WORKER;

EID: 3042700205     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380401900509     Document Type: Article

References (139)

1. Sillanpaa M: Epilepsy in children: Prevalence, disability, and handicap. Epilepsia 1992;33:444-449.
2. Sillanpaa M: Remission of seizures and prediction of intractability in long-term follow-up. Epilepsia 1993;34:930-936.
3. Sillanpaa M: Long-term outcome of epilepsy. Epileptic Disord 2002;2:79-88.
4. Sillanpaa M, Jalava M, Kaleva O, Shinnar S: Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338:1715-1722.
5. Kerr M, Boley C: Multidisciplinary and multiagency contribution to care for those with learning disability who have epilepsy. Epilepsia 2001;42(Suppl 1):57-58.
6. Cereghina JJ, Cole CH: A multidisciplinary approach to services for the epileptic. HSMHA Health Rep 1971;86:355-371.
7. Ott D, Siddarth P, Ghurbani S, et al: Behavioral disorders in pediatric epilepsy: Unmet psychiatric need. Epilepsia 2003;44:591-597.
8. Noebels JL: Exploring new gene discoveries in idiopathic generalized epilepsy. Epilepsia 2003;44(Suppl 2):16-21.
9. Lerche H, Biervert C, Alekov AK, et al: A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol 1999;46:305-312.
10. Singh NA, Charlier C, Stauffer D, et al: A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998;18:25-29.
11. Zuberi SM, Eunson LH, Spauschus A, et al: A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999;122:817-825.
12. Chandy KG, Fantino E, Wittekindt O, et al: Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: A candidate for schizophrenia and bipolar disorder? Mol Psychiatry 1998;3:32-37.
13. Guy CA, Bowen T, Williams N, et al: No association between a polymorphic CAG repeat in the human potassium channel gene hKCa3 and bipolar disorder. Am J Med Genet 1999;88:57-60.
14. Burgess DL, Noebels JL: Single gene defects in mice: The role of voltage-dependent calcium channels in absence models. Epilepsy Res 1999;36:111-122.
15. Jouvenceau A, Eunson LH, Spauschus A, et al: Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001;358:801-807.
16. Fletcher CF, Frankel WN: Ataxic mouse mutants and molecular mechanisms of absence epilepsy. Hum Mol Genet 1999;8: 1907-1912.
17. Silverstone PH, Birkett L: Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: A retrospective study. J Psychiatry Neurosci 2000;25:276-280.
18. Pazzaglia PJ, Post RM, Ketter TA, et al: Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol 1998;18:404-413.
19. de Falco FA, Bartiromo U, Majello L, et al: Calcium antagonist nimodipine in intractable epilepsy. Epilepsia 1992;33:343-345.
20. Claes L, Del-Favero J, Ceulemans B, et al: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-1332.
21. Escayg A, Heils A, MacDonald BT, et al: A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus - And prevalence of variants in patients with epilepsy. Am J Hum Genet 2001;68:866-873.
22. Wallace RH, Scheffer IE, Barnett S, et al: Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001;68:859-865.
23. Wallace RH, Scheffer IE, Parasivam G, et al: Generalized epilepsy with febrile seizures plus: Mutation of the sodium channel subunit SCN1Bc. Neurology 2002;58:1426-1429.
24. Sugawara T, Mazaki-Miyazaki E, Ito M, et al: Nav1.1 mutations cause febrile seizures associated with afebrile partial seizures. Neurology 2001;57:703-705.
25. Heron SE, Crossland KM, Andermann E, et al: Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002;360:851-852.
26. Gong B, Rhodes KJ, Bekele-Arcuri Z, Trimmer JS: Type I and type II Na(+) alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J Comp Neurol 1999;412:342-352.
27. Kearney JA, Plummer NW, Smith MR, et al: A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 2001;102:307-317.
28. Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH: Phenytoin as an antimanic anticonvulsant: A controlled study. Am J Psychiatry 2000;157:463-465.
29. Xie X, Hagan RM: Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 1998;38:119-130.
30. Beck C, Moulard B, Steinlein O, et al: A nonsense mutation in the α4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI). Neurobiol Dis 1994;1:95-99.
31. Phillips HA, Favre I, Kirkpatrick M, et al: CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001; 68:225-231.
32. Hennings EC, Kiss JP, De Oliveira K, et al: Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J Neurochem 1999;73:1043-1050.
33. Lai IC, Hong CJ, Tsai SJ: Association of nicotinic-receptor variants and major depressive disorder. J Affect Disord 2001;66:79-82.
34. US Department of Health and Human Services: Mental Health: A Report of the Surgeon General. Rockville, MD, US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999.
35. Austin JK, Risinger MW, Beckett L: Correlates of behavioral problems in children with epilepsy. Epilepsia 1992;33:1115-1122.
36. Caplan R, Arbelle S, Guthrie D, et al: Formal thought disorder and psychopathology in pediatric primary generalized and complex partial epilepsy. J Am Acad Child Adolesc Psychiatry 1997;36:1286-1294.
37. Dunn DW, Austin JK: Behavioral issues in pediatric epilepsy. Neurology 1999;53(Suppl 2):S96-S100.
38. Austin JK, Huster GA, Dunn DW, Risinger MW. Adolescents with active or inactive epilepsy or asthma: A comparison of quality of life. Epilepsia 1996;37:1228-1238.
39. McDermott S, Mani S, Krishnaswami S: A population-based analysis of specific behavior problems associated with childhood seizures. J Epilepsy 1995;8:110-118.
40. Hoare P: The development of psychiatric disorder among school-children with epilepsy. Dev Med Child Neurol 1984;26:3-13.
41. Rutter M, Graham P, Yule W: A neuropsychiatric study in childhood. Clin Dev Med 1970;35/36:175-185.
42. Besag FM: Childhood epilepsy in relation to mental handicap and behavioural disorders. J Child Psychol Psychiatry 2002;43:103-131.
43. Hoare P, Kerley S: Psychosocial adjustment of children with chronic epilepsy and their families. Dev Med Child Neurol 1991;33:201-215.
44. Caplan R, Arbelle S, Magharious W, et al: Psychopathology in pediatric complex partial and primary generalized epilepsy. Dev Med Child Neurol 1998;40:805-811.
45. Costello EJ, Shugart MA: Above and below the threshold: Severity of psychiatric symptoms and functional impairment in a pediatric sample. Pediatrics 1992;90:359-368.
46. Ettinger AB, Weisbrot DM, Nolan EE, et al: Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998;39:595-599.
47. Dunn DW, Austin JK, Huster GA: Symptoms of depression in adolescents with epilepsy. J Am Acad Child Adolesc Psychiatry 1999;38:1132-1138.
48. Brent DA, Crumrine, PK, Varma R, et al: Phenobarbital treatment and major depressive disorder in children with epilepsy: A naturalistic follow-up. Pediatrics 1990;85:1086-1091.
49. Austin JK, Smith MS, Risinger MW, McNelis AM: Childhood epilepsy and asthma: Comparison of quality of life. Epilepsia 1994;35:608-615.
50. Mandelbaum DE, Burack G: The effect of seizure type and medication on cognitive and behavioral functioning in children with idiopathic epilepsy. Dev Med Child Neurol 1997;39:731-735.
51. Lindsay JJ, Ounsted C, Richards P: Long-term outcome in children with temporal lobe seizures. III: Psychiatric aspects in childhood and adult life. Dev Med Child Neurol 1979;21:630-636.
52. Bailet LL, Turk WR: The impact of childhood epilepsy on neurocognitive and behavioral performance: A prospective longitudinal study. Epilepsia 2000;41:426-431.
53. Austin JK, Harezlak J, Dunn DW, et al: Behavior problems in children before first recognized seizures. Pediatrics 2001;107:115-122.
54. Austin JK, Dunn DW, Caffrey HM, et al: Recurrent seizures and behavior problems in children with first recognized seizures: A prospective study. Epilepsia 2002;43:1564-1573.
55. Austin JK, McDermott N: Parental attitude and coping behaviors in families of children with epilepsy. J Neurosci Nurs 1988;20:174-179.
56. Hoare P: Psychiatric disturbance in the families of epileptic children. Dev Med Child Neurol 1984;26:14-19.
57. Hermann B, Whitman S: Psychosocial predictors of interictal depression. J Epilepsy 1989;2:231-237.
58. Mitchell WG, Lee H, Chavez JM, Guzman BL: Academic under-achievement in children with epilepsy. J Child Neurol 1991;6:65-72.
59. Hermann B, Whitman S, Hughes J, et al: Multietiological determinants of psychopathology and social competence in children with epilepsy. Epilepsy Res 1988;2:51-60.
60. Hermann B: Neuropsychological functioning and psychopathology in children with epilepsy. Epilepsia 1982;23:545-554.
61. Williams J, Sharp GB, Lange B, et al: The effects of seizure type, level of seizure control, and antiepileptic drugs on memory and attention skills in children with epilepsy. Dev Neuropsychol 1996;12:241-253.
62. Weglage J, Demsky A, Pietsch M, Kurlemann G: Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures. Dev Med Child Neurol 1997;39:646-651.
63. Williams J, Shart G, Bates S, et al: Academic achievement and behavioral ratings in children with absence and complex partial epilepsy. Educ Treat Child 1996;19:143-152.
64. Austin JK, Huberty TJ, Huster GA, Dunn DW: Does academic achievement in children with epilepsy change over time? Dev Med Child Neurol 1999;41:473-479.
65. Vermeulen J, Kortstee SW, Alpherts WC, Aldenkamp AP: Cognitive performance in learning disabled children with and without epilepsy. Seizure 1994;3:13-21.
66. Ott D, Caplan R, Guthrie D, et al: Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence. J Am Acad Child Adolesc Psychiatry 2001;40:907-914.
67. Mitchell WG, Scheier LM, Baker SA: Psychosocial, behavioral and medical outcomes in children with epilepsy: A developmental risk factor model using longitudinal data. Pediatrics 1994;94:471-477.
68. Stores G: A clinical approach to poorly controlled seizures in children. Br J Hosp Med 1992:48:93-98.
69. Sabaz M, Cairns D, Lawson J, et al: The health-related quality of life of children with refractory epilepsy: A comparison of those with and without intellectual disability. Epilepsia 2001;42:621-628.
70. Aldenkamp AP, Overweg-Plandsoen WC, Arends J: An open, non-randomized clinical comparative study evaluating the effect of epilepsy on learning. J Child Neurol 1999;14:795-800.
71. Caplan R, Guthrie D, Komo S, et al: Social communication in children with epilepsy. J Child Psychol Psychiatry 2002;43:245-253.
72. Camfield CS, Camfield PR, Smith P, et al: Biologic factors as predictors of social outcome of epilepsy in intellectually normal children: A population-based study. J Pediatr 1993;122:869-873.
73. Whitman S, Hermann B, Black R, Chhabria S: Psychopathology and seizure type in children with epilepsy. Psychol Med 1982;12:843-853.
74. Bulteau C, Jambaque I, Viguier D, et al: Epileptic syndromes, cognitive assessment and school placement: A study of 251 children. Dev Med Child Neurol 2000;42:319-327.
75. Smith ML, Elliot IM, Lach L: Cognitive skills in children with intractable epilepsy: Comparison of surgical and nonsurgical candidates. Epilepsia 2002;43:631-637.
76. Vasconcellos E, Wyllie E, Sullivan S, et al: Mental retardation in pediatric candidates for epilepsy surgery: The role of early seizure onset. Epilepsia 2001;42:268-274.
77. Huttenlocher PR, Hapke RJ: A follow-up study of intractable seizures in childhood. Ann Neurol 1990;28:699-705.
78. Sattler JM: Assessment of Children, 3rd ed. San Diego, Jerome M. Sattler, 1988.
79. Seidenberg M, Beck N, Geisser M, et al: Academic achievement of children with epilepsy. Epilepsia 1986;27:753-759.
80. Huberty TJ, Austin JK, Risinger MW, McNelis AM: Classroom performance and adaptive skills in children with epilepsy. J School Psychol 1992;30:331-342.
81. Oostrom KJ, Schouten A, Kruitwagen CL, et al: Attention deficits are not characteristic of schoolchildren with newly diagnosed idiopathic or cryptogenic epilepsy. Epilepsia 2002;43:301-310.
82. Wamboldt MZ, Wamboldt FS: Role of the family in the onset and outcome of childhood disorders: Selected research findings. J Am Acad Child Adolesc Psychiatry 2000;39:1212-1219.
83. Neale MC, Cardon LR: Methodology for Genetic Studies of Twins and Their Families. Dordecht, the Netherlands, Kluwer Academic, 1992.
84. Eaves LJ, Silberg JL, Maes HH, et al: Genetics and developmental psychopathology: 2. The main effects of genes and environment on behavioral problems in the Virginia Twin Study of Adolescent Behavioral Development. J Child Psychol Psychiatry 1997;38:965-980.
85. Hewit J, Silberg J, Rutter M, et al: Genetics and developmental psychopathology, 1: Phenotypic assessment in the Virginia Twin Study of Adolescent Behavioral Development. J Child Psychol Psychiatry 1997;38:943-963.
86. Reiss D, Hetherington EM, Plomin R, et al: Genetic questions for environmental studies: Differential parenting and psychopathology in adolescence. Arch Gen Psychiatry 1995;52:925-936.
87. Orvaschel H, Walsh-Allis G, Ye WJ: Psychopathology in children of parents with recurrent depression. J Abnorm Child Psychol 1988;16:17-28.
88. Hammen C: Vulnerability to depression: Personal, situational and family aspects, in Ingram RE (ed): Contemporary Psychological Approaches to Depression: Theory, Research, and Treatment. Dordrecht, The Netherlands, Kluwer Academic/Plenum Publishers, 1990, 59-69.
89. Weissman MM, Fendrich M, Warner V, Wickramaratne P: Incidence of psychiatric disorder in offspring at high and low risk for depression. J Am Acad Child Adolesc Psychiatry 1992;31:640-648.
90. Watt N, Anthony EJ, Wynne L, Rolf JE (eds): Children at Risk for Schizophrenia. New York, Cambridge University Press, 1984.
91. Schulsinger F, Knop J, Goodwin G: A prospective study of young men at high risk for alcoholism. Social and psychological characteristics. Arch Gen Psychiatry 1986;43:755-760.
92. Befera M, Barkley RA: Hyperactive and normal boys and girls: Mother-child interactions, parent psychiatric status, and child psychopathology. J Child Psychol Psychiatry 1985;26:439-452.
93. Mash EJ, Johnston C: Determinants of parenting stress: Illustrations from families of hyperactive children and families of physically abused children. J Clin Child Psychol 1990;19:313-328.
94. Lothman DJ, Pianta RC, Clarson SM: Mother-child interaction in children with epilepsy: Relations with child competence. J Epilepsy 1990;3:157-163.
95. Shore CP, Austin JK, Huster GA, Dunn DW: Identifying risk factors for maternal depression in families of adolescents with epilepsy. J Spec Pediatr Nurs 2002;7:71-80.
96. Bourgeois BF, Prensky AL, Palkes HS, et al: Intelligence in epilepsy: A prospective study in children. Ann Neurol 1983;14:438-444.
97. Bernstein JH, Prather PA, Rey-Casserly C: Neuropsychological assessment in preoperative and postoperative evaluation. Neurosurg Clin N Am 1995;6:443-454.
98. Seidenberg M, O'Leary DS, Giordani B, et al: Test-retest IQ changes of epilepsy patients: Assessing the influence of practice effects. J Clin Neuropsychol 1981;3:237-255.
99. Aldenkamp AP, Alpherts WC, DeBruine-Seeder D, Dekker MJ: Test-retest variability in children with epilepsy - A comparison of WISC-R subtest profiles. Epilepsy Res 1990;7:165-172.
100. Stores G: Studies of attention and seizure disorders. Dev Med Child Neurol 1973;15:376-382.
101. Semrud-Clikeman M, Wical B: Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40:211-215.
102. Lyon GR, Krasnegor NA: Attention, Memory, and Executive Function. Baltimore, Paul H. Brookes, 1996.
103. Riva D, Saletti V, Nichelli F, Bulgheroni S: Neuropsychologic effects of frontal lobe epilepsy in children. J Child Neurol 2002;17:661-667.
104. Culhane-Shelburne K, Chapieski L, Hiscock M, Glaze D: Executive functions in children with frontal and temporal lobe epilepsy. J Int Neuropsychol Soc 2002;8:623-632.
105. Gioia GA, Isquith PK, Guy SC, Kenworthy L: Behavior Rating Inventory of Executive Function: Professional Manual. Odessa, FL, Psychological Assessment Resources, 2000.
106. Blennow G, Heijbel J, Sandstedt P, Tonnby B: Discontinuation of antiepileptic drugs in children who have outgrown epilepsy: Effects on cognitive function. Epilepsia 1990;31(Suppl 4):S50-S53.
107. Dam M: Children with epilepsy: The effect of seizures, syndromes, and etiological factors on cognitive functioning. Epilepsia 1990;31:S26-S29.
108. Williams J, Phillips T, Griebel ML, et al: Patterns of memory performance in children with controlled epilepsy on the CVLT-C. Neuropsychol Dev Cogn Sect C Child Neuropsychol 2001;7:15-20.
109. Aldenkamp A, van Bronswijk K, Braken M, et al: A clinical comparative study evaluating the effect of epilepsy versus ADHD on timed cognitive tasks in children. Neuropsychol Dev Cogn Sect C Child Neuropsychol 2000;6:209-217.
110. Aldenkamp AP, Alpherts WC, Blennow G, et al: Withdrawal of antiepileptic medication in children - Effects on cognitive function: The Multicentre Holmfrid Study. Neurology 1993;43:41-51.
111. Harden CL, Lazar LM, Pick LH, et al: A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40:1129-1134.
112. Dimond KR, Pande AC, Lamoreaux L, Pierce MW: Effect of gabapentin (Neurontin) on mood and well being in patients with epilepsy [published correction appears in Prog Neuropsychopharmacol Biol Psychiatry 1996;20:1081]. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:407-417.
113. Sackellares JC, Kwong WJ, Vuong A, et al: Lamotrigine monotherapy improves health-related quality of life in epilepsy: A double-blind comparison with valproate. Epilepsy Behav 2002;3:376-382.
114. Edwards KR, Sackellares JC, Vuong A, et al: Lamotrigine monotherapy improves depressive symptoms in epilepsy: A double-blind comparison with valproate. Epilepsy Behav 2001;2:28-36.
115. Kalogjera-Sackellares D, Sackellares JC: Improvement in depression associated with partial epilepsy in patients treated with lamotrigine. Epilepsy Behav 2002;3:510-516.
116. Dodrill CB, Arnett JL, Deaton R, et al: Tiagabine versus phenytoin and carbamazepine as add-on therapies: Effects on abilities, adjustment, and mood. Epilepsy Res 2000;42:123-132.
117. Dodrill CB, Arnett JL, Shu V, et al: Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsia 1998;39:33-42.
118. Mortimore C, Trimble M, Emmers E: Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure 1998;7:359-364.
119. Crawford P, Brown S, Kerr M, and the Parke Davis Clinical Trials Group: A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy. Seizure 2001;10:107-115.
120. Dodrill CB, Arnett JL, Hayes AG, et al: Cognitive abilities and adjustment with gabapentin: Results of a multisite study. Epilepsy Res 1999;35:109-121.
121. Leach JP, Girvan J, Paul A, Brodie MJ: Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62:372-376.
122. Ettinger AB, Weisbrot DM, Saracco J, et al: Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998;39:874-877.
123. Placidi F, Marciani MG, Diomedi M, et al: Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. Acta Neurol Scand 2000;102:81-86.
124. Marciani MG, Stanzione P, Mattia D, et al: Lamotrigine add-on therapy in focal epilepsy: Electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998;21:41-47.
125. Banks GK, Beran RG: Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol 1991;28:230-237.
126. Neyens LG, Alpherts WC, Aldenkamp AP: Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:411-419.
127. Aikia M, Kalviainen R, Sivenius J, et al: Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow up. Epilepsy Res 1992;11:199-203.
128. Dodrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997;48:1025-1031.
129. Kalviainen R, Aikia M, Mervaala E, et al: Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res 1996;25:291-297.
130. Sveinbjornsdottir S, Sander JW, Patsalos PN, et al: Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure 1994;3:29-35.
131. Aldenkamp AP, Baker G, Mulder OG, et al: A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
132. Novak G: Recognition and management of psychiatric disorders in childhood epilepsy, in Ettinger AB, Devinsky O (eds): Managing Epilepsy and Co-existing Disorders. Boston, Butterworth-Heinemann, 2002, 389-406.
133. Kanner AM: Psychiatric comorbidity in patients with developmental disorders and epilepsy: A practical approach to its diagnosis and treatment. Epilepsy Behav 2002;3(6S1):7-13.
134. Wolf SM, Shinnar S, Kang H, et al: Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1995;36:1203-1205.
135. Beran RG, Gibson RJ: Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 1998;39:280-282.
136. Achenbach TM, Rescorla LA: Manual for ASEBA School-Age Forms & Profiles. Burlington, VT, University of Vermont, Research Center for Children, Youth, & Families, 2001.
137. Raybaud C, Guye M, Mancini J, Girard N: Neuroimaging of epilepsy in children. Magn Reson Imaging Clin N Am 2001;9:121-147.
138. Strain JR, Kushner DC, Babcock DS, et al: Imaging of the pediatric patient with seizures. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(Suppl):787-800.
139. Chuang NA, Otsubo H, Chuang SH: Magnetic resonance imaging in pediatric epilepsy. Top Magn Reson Imaging 2002;13:39-60.